News
XORTX Presents New Proof of Concept Data at American Society of Nephrology
Xanthine Oxidase Inhibition with XRx-008 Blocks Uric Acid Induced Increase in Total Kidney Weight in Polycystic Kidney Disease
CALGARY, AB - November 3, 2022 - XORTX Therapeutics Inc.
First Hydrogen Encouraged by Mini-Budget Announcement
Vancouver, B.C., November 4, 2022 - Vancouver, British Columbia - First Hydrogen Corp. (“FIRST HYDROGEN” or the “Company”) (TSXV: FHYD) (OTC: FHYDF) (FSE: FIT) is pleased with Canada’s
Reliq Health Technologies, Inc. Announces 50 New Skilled Nursing Facilities Clients in Florida
HAMILTON, ON, November 4, 2022 / - Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that
Spey Resources Corp. Announces Addition of Jose Gustavo de Castro Alem to the Advisory Board
Vancouver, British Columbia, Nov. 02, 2022 -- Spey Resources Corp. (CSE: SPEY) (OTC: SPEYF) (FRA: 2JS) ("Spey” or the "Company") is pleased to announce the addition of José Gustavo de
Quantum Battery Readies Portfolio for Investment
Vancouver, British Columbia, November 3rd, 2022 - Quantum Battery Metals Corp. (CSE: QBAT; OTC: BRVVF; FRA: 23B0) (“Quantum” or the “Company”) announces that management has received
Denarius Files National Instrument 43-101 Technical Report for Its Polymetallic Lomero-Poyatos Project in Southern Spain
TORONTO, CANADA, Wednesday, November 2, 2022 - Denarius Metals Corp. (“Denarius” or “the Company” - https://www.commodity-tv.com/ondemand/companies/profil/denarius-silver-corp/) (TSXV:
dynaCERT’s Pilot Programme Leads to Purchase of Additional HydraGEN™ Units for Fleet Vehicles of Alectra Utilities
TORONTO, ON--(November 03, 2022). dynaCERT Inc. (TSX: DYA)
Polaris Renewable Energy Announces Q3 2022 Results
TORONTO, ON / ACCESSWIRE / November 3, 2022 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results
XORTX Announces Participation at Upcoming Investor Conferences
CALGARY, AB - November 3, 2022 - XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on
Trintech Client Serco Named Winner in 15th Annual Ventana Research Digital Leadership Awards
Recognized for increasing efficiencies and reducing enterprise risk by automating reconciliation and financial close processes with Trintech's Cadency Platform
DALLAS, TX / ACCESSWIRE /
Recharge Announces New Drilling Permit for Brussels Creek Project as Drilling Continues to Target Production Depth at Pocitos 1 Lithium Brine Project
Vancouver, BC – November 3, 2022 - Recharge Resources Ltd. (‘Recharge’) (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) issued an update today for its upcoming fully-funded drill program at
Trillion Energy Announces Commencement of the Second Well in its Multiwell Program
The Akcakoca-3 recompletion at the SASB gas field has now commenced
November 3, 2022 - Vancouver,
Polaris Renewable Energy Declares Quarterly Dividend
TORONTO, ON / ACCESSWIRE / November 3, 2022 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to announce that its board of directors has
Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System™ for Type 1 Diabetes
- Sernova plans to begin enrollment of second cohort in the coming weeks and implant multiple patients with the enhanced capacity 10-channel Cell Pouch before the end of 2022
-
Aduro Selected for Shell GameChanger Program
Sarnia, ON, November 3, 2022 - Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based technologies to
First Patient Dosed in Clairvoyant’s Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder
VANCOUVER, BC / ACCESSWIRE / November 3, 2022 / Clairvoyant Therapeutics ("Clairvoyant"), a clinical stage biotech company focused on the development of psychedelic drug therapies for the
Reakiro Honored with Two Awards
At this year's World CBD Awards, Held in Barcelona in October, Reakiro was Honored with Two Awards - Best Extract-Based Tincture and Most Charitable Company
LONDON, UK / ACCESSWIRE /
EGF Theramed Looking to Acquire Retail Cannabis Assets
Vancouver, BC, November 2nd, 2022 - EGF Theramed Health Corp. (CSE:TMED / OTC:EVAHF / FRANKFURT: AUHP) (the “Company” of “EGF”) has begun to look into the acquisition of overleveraged
Pathfinder Forecasts Winter Occupancy to Exceed 50%
VANCOUVER, B.C., November 2, 2022 – Pathfinder Ventures Inc. (TSXV: RV) (OTCQB: RVRVF) (the “Company,” “RV” or “Pathfinder.”) is pleased to report a 47% booked occupancy rate for Q4 2022 and
NurExone Announces Plan to Submit Pre-Investigational New Drug Meeting Request to U.S. Food and Drug Administration
- The U.S. Food and Drug Administration (FDA) informed NurExone that it is at the appropriate stage of its product development for a pre-Investigational New Drug (pre-IND) meeting
-
Patriot Battery Metals Provides Exploration and Corporate Update
November 2, 2022 - Vancouver, BC, Canada. Patriot Battery Metals Inc. (the “Company” or “Patriot”) (TSX-V: PMET) (OTCQB: PMETF) (FSE: R9GA) is pleased to provide a mineral exploration
PyroGenesis Announces Passing Annual Quality Audit of its 3D Printing Metal Powder Business Line
Provides Corporate Update, Business Unit Expanding.
MONTREAL, Quebec (November 2 2022) - PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech
Troilus Discovers New 4.4 Km Gold Trend With Surface Samples Up to 32.2 G/T and 25.4 G/T Gold; Provides Summary of Regional Exploration
November 2, 2022, Montreal, Quebec – Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF) provides an overview
Medaro Completes Additional Earn-Ins under Joint Venture Agreement to Develop Lithium Extraction Technology
Commences Planning for Pilot Plant
November 2, 2022 - Vancouver, B.C. - Medaro Mining Corp. (CSE:MEDA) (OTC: MEDAF) (FWB: 1ZY) (“Medaro” or the “Company”) is pleased to announce the
Sovereign Signs Rutile Offtake MOU with Chemours
MOU signed for supply of 20,000 tonnes of natural rutile per annum from Kasiya to US-based Chemours, one of the world’s largest producers of high-quality titanium dioxide pigments